LATEST NEWS
December 31, 2019 | Company Announcements
Bavarian Nordic Announces Closing of Acquisition of Rabipur/RabAvert and Encepur from GlaxoSmithKline and Updates Year-end Cash PreparednessDecember 17, 2019 | Company Announcements
Bavarian Nordic Announces the Sale of Priority Review VoucherDecember 13, 2019 | Company Announcements
Bavarian Nordic Receives Antitrust Clearance for Acquisition of Rabipur/RabAvert and Encepur from GlaxoSmithKline